The future is so bright and obvious for INSM ... IPLEX & ARIKACE
Very soon we will have two FDA approved drugs, 80 patients, millions in cash..... NO DEBT We now have a leader who has a proven record and he will move INSM into the very bright future. Speculation is easy but reality is guaranteed. UP we GO..How high - no one knows. Best Wishes & Happy Easter
but they said in their 1q earnings release they will be out of cash in 2014 and with the costs associated with arikace phase 3 trials more likely they will need financing this fall. the problem is the 10-year note is soaring toward 5% suggesting it will be very difficult to sell corporate debt notes in 2014 without giving away the whole company to bond holders.